Description

Sandborn and Hanauer developed an algorithm for infusing infliximab to a patient with Crohn's disease. the authors are from the Mayo Clinic and the University of Chicago.


 

Step 1: Inquire for contraindications (known hypersensitivity to mouse proteins or other components of the product). Stop if present.

 

Step 2: Weigh the patient and calculate the dose at 5 mg/kg. Prepare the infusion solution with a final volume of 250 mL.

 

Step 3: Start an IV with a "Y" connection between isotonic saline and the infliximab solution.

 

Step 4: Give premedication.

(4a) If this is the first infusion, then no premedication is usually needed.

(4b) If the patient has received a previous infusion without reaction, then consider one of the following:

(4b1) diphenhydramine 25-50 mg po or IV

(4b2) acetaminophen 650 mg po

(4c) If the patient has had a reaction to a previous infusion, then give one or more of the following:

(4c1) diphenhydramine 25-50 mg po or IV

(4c2) acetaminophen 650 mg po

(4c3) prednisone 40 mg po or methylprednisone 100 mg IV

 

Step 5: Start infusing the infliximab solution and monitor the patient every 15 minutes. The infusion should be stopped if significant symptoms develop.

 

Infusion rate titration schedule:

(a) 10 mL/hr over 15 minutes (2.5 mL)

(b) 20 mL/hr over 15 minutes (5.0 mL)

(c) 40 mL/hr over 15 minutes (10 mL)

(d) 80 mL/hr over 15 minutes (20 mL)

(e) 150 mL/hr over 30 minutes (75 mL)

(f) 250 mL/hr over 33 minutes (137.5 mL) for total 250 mL

 

An alternative approach is to administer the infliximab solution as a slow infusion of 2 mL per minute.

 

Step 6: Monitor vital signs for 30 minutes after the infusion is completed. Ask the patient if there are any symptoms to note.

 


To read more or access our algorithms and calculators, please log in or register.